Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Aptose Biosciences, Inc. (APTO)

« Back to company index

APTO Chatter Timeline

Stock Ticker for APTO

Most Active Tweeters for APTO

UserTweets
@FlashAlert_me 2
@FTPOS10 1
@DanielJanicemc 1
@newsfilterio 1
@investor_feed 1

Recent Tweets for APTO

newsfilterio @newsfilterio
Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC $APTO https://t.co/nkQMLc07ms
November 30th 2022, 3:11am
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed] filed form 424B5 on November 29, 16:43:06 https://t.co/omcQHRXyiy
November 29th 2022, 9:11pm
FTPOS10 @FTPOS10
RT @JasonRutkowski3: $APTO this is a long trap. You see this a few times a month. Stock pushes on insane volume, fades, hard, then it start…
November 28th 2022, 8:11pm
tuduylinh @tuduylinh
@PersimmonTI $apto has always been crapto, the best is to return to sender
November 28th 2022, 1:11am
PersimmonTI @PersimmonTI
$APTO Took another look, and will pass going into ASH update. Tuspetinib looks like it could hold promise, but… https://t.co/la5Cg3WY9C
November 27th 2022, 4:11pm
paolinoLA @paolinoLA
@PersimmonTI Any thought on $apto of recent? I know you have been plenty critical
November 26th 2022, 4:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed] filed form 8-K on November 25, 16:30:18 https://t.co/F5o6aOuLfc
November 25th 2022, 9:11pm
investor_feed @investor_feed
$APTO 8-K Aptose Biosciences (25 Nov, 4:30pm) ? Termination of a Material Definitive Agreement… https://t.co/z4pNlHcnLx
November 25th 2022, 9:11pm
DanielJanicemc @DanielJanicemc
$APTO Don't miss the next move in a few hours.?? https://t.co/B1LQVAe3Ed
November 22nd 2022, 6:11pm
beanz789 @beanz789
@GantosJ $apto still your top pick?
November 18th 2022, 3:11am
StckPro @StckPro
$APTO NEW ARTICLE : Aptose Biosciences (APTO) Gets a Buy from H.C. Wainwright https://t.co/L6xqfZpha9 Get all the l… https://t.co/gK9e0TRTsQ
November 17th 2022, 3:11pm
1stOncology @1stOncology
#Aptose Treats First Patient with Continuous Dosing of New #G3 Formulation of #Luxeptinib $APTO https://t.co/WXbRVy7yCK
November 15th 2022, 8:11am
newsfilterio @newsfilterio
Aptose Treats First Patient with Continuous Dosing of New "G3" Formulation of Luxeptinib $APTO https://t.co/i0ZS4icr7V
November 14th 2022, 8:11pm
Tickeron @Tickeron
$APTO in -14.47% Downtrend, declining for three consecutive days on November 9, 2022. View odds for this and other… https://t.co/lEpcJA106x
November 14th 2022, 3:11pm
Gambiste1 @Gambiste1
RT @GantosJ: $APTO Lux is back in track with G3 formulation in #AML Aptose Treats First Patient with Continuous Dosing of New “G3” Formula…
November 14th 2022, 1:11pm
Gambiste1 @Gambiste1
RT @GantosJ: $APTO Modeling of the PK properties of G3 predicts steady-state plasma exposure from continuous dosing with 50mg of G3 Q12h sh…
November 14th 2022, 1:11pm
GantosJ @GantosJ
$APTO Modeling of the PK properties of G3 predicts steady-state plasma exposure from continuous dosing with 50mg of… https://t.co/nMQkOf1Fii
November 14th 2022, 12:11pm
GantosJ @GantosJ
$APTO Lux is back in track with G3 formulation in #AML Aptose Treats First Patient with Continuous Dosing of New “… https://t.co/a8kK1vVxNF
November 14th 2022, 12:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed] filed form 8-K on November 14, 07:35:17 https://t.co/SR1UaMrM5M
November 14th 2022, 12:11pm
StckPro @StckPro
$APTO NEW ARTICLE : Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib… https://t.co/5gUpwaTfXl
November 14th 2022, 12:11pm
investor_feed @investor_feed
$APTO 8-K Aptose Biosciences (14 Nov, 7:35am) ? Regulation FD Disclosure; Financial Statements and Exhibits… https://t.co/Ypzl1xq4A2
November 14th 2022, 12:11pm
AnExpertOne1 @AnExpertOne1
$APTO Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib November 14, 2022… https://t.co/wrwjat5awx
November 14th 2022, 12:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed]: Issued Press Release on November 14, 07:30:00: Aptose Treats First Patient with Continuous Do… https://t.co/PyXgj0tvpn
November 14th 2022, 12:11pm
stonkmooncom @stonkmooncom
$APTO 2022-11-14 07:30 ET Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptin… https://t.co/O1d3ogz89m
November 14th 2022, 12:11pm
Tradesense_me @Tradesense_me
$APTO ? ? Press Release Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib… https://t.co/iqhLAknBSa
November 14th 2022, 12:11pm
StockNewsBot2 @StockNewsBot2
$APTO Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib https://t.co/YAHrAc6QxD
November 14th 2022, 12:11pm
FastestAlert @FastestAlert
$APTO Aptose Treats First Patient With Continuous Dosing Of New “G3” Formulation Of Luxeptinib Stock News Alerts In Bio
November 14th 2022, 12:11pm
stock_titan @stock_titan
$APTO Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib https://t.co/ozfTqOG3jP
November 14th 2022, 12:11pm
Tickeron @Tickeron
$APTO in -14.47% Downtrend, sliding for three consecutive days on November 9, 2022. View odds for this and other in… https://t.co/5MM5OeaYRx
November 13th 2022, 10:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed, acc.~90%, always check] Earnings Release 2022-05-09T20:01:00: Q1: GAAP EPS of -$0.12 https://t.co/rX7P1xsiNO
November 11th 2022, 4:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed, acc.~90%, always check] Earnings Release 2022-08-02T20:01:00: Q2: GAAP EPS of -$0.11 https://t.co/QEyhqj6oSV
November 11th 2022, 4:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed, acc.~90%, always check] Earnings Release 2022-11-01T20:01:00: Q3: GAAP EPS of -$0.11 https://t.co/XbmhxZ2g9A
November 11th 2022, 4:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed, acc.~90%, always check] Earnings Release 2022-08-02T20:01:00: Q2: GAAP EPS of -$0.11 https://t.co/tc8AV4nTvC
November 11th 2022, 4:11pm
FlashAlert_me @FlashAlert_me
$APTO [15s. delayed, acc.~90%, always check] Earnings Release 2022-05-31T20:15:00: https://t.co/I2IdlqKpHI
November 11th 2022, 4:11pm
AnExpertOne1 @AnExpertOne1
Hard to believe that $APTO is falling back under $60 Million valuation, but it is anemic Volume; even the nasty rob… https://t.co/OK3AAD9iW1
November 9th 2022, 8:11pm
shortablestocks @shortablestocks
$APTO is short sale restricted for 2022-11-09. https://t.co/bgYQgrKTP2
November 9th 2022, 2:11pm
datadili @datadili
Aptose Biosciences Inc. is up 3.95% in the pre-market $APTO
November 8th 2022, 12:11pm
biolongtilbroke @biolongtilbroke
I’m not even in $APTO but I want that to hit a home-run for the patients, and also for the unduly punished bag-holders.
November 8th 2022, 1:11am
5up3r_m4r10 @5up3r_m4r10
RT @5up3r_m4r10: $APTO tuspetinib ASH ? We already have reported significant clinical activity and complete remissions across three dose l…
November 8th 2022, 12:11am
datadili @datadili
Aptose Biosciences Inc. is down -5.00% after hours $APTO
November 7th 2022, 9:11pm
biotech_cash @biotech_cash
RT @SeekingAlpha: $APS:CA $APTO - Aptose Biosciences: Expansion Studies Could Rebuild Investor Interest In This Beaten-Down Biotech. https:…
November 7th 2022, 7:11pm
SeekingAlpha @SeekingAlpha
$APS:CA $APTO - Aptose Biosciences: Expansion Studies Could Rebuild Investor Interest In This Beaten-Down Biotech.… https://t.co/J6vlExYRMq
November 7th 2022, 7:11pm
ManseSin @ManseSin
$apto is set and ready for a run up: ~ https://t.co/PhGVtDDuVz
November 7th 2022, 5:11pm
Maximus_Holla @Maximus_Holla
$APTO are we going to see 1 before Ash Dec data ? @semodough https://t.co/JQlnX17bQ1
November 7th 2022, 4:11pm
Harrypotar12 @Harrypotar12
$apto Is set and ready for a run up... https://t.co/ULoARJFB57
November 7th 2022, 2:11pm
datadili @datadili
Aptose Biosciences Inc. is up 14.59% in the pre-market $APTO
November 7th 2022, 12:11pm
Tickeron @Tickeron
$APTO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/XsOPSCXH3A
November 6th 2022, 8:11am
5up3r_m4r10 @5up3r_m4r10
$APTO tuspetinib ASH ? We already have reported significant clinical activity and complete remissions across three… https://t.co/QB9cXGQIqV
November 5th 2022, 1:11pm
zhyhljthx10205 @zhyhljthx10205
$APTO's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above snal line. View odds for t… https://t.co/Ox674y1Su1
November 5th 2022, 12:11pm
Tickeron @Tickeron
$APTO's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/47VRmkRcJF
November 5th 2022, 11:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.